To this date, drug treatment for unresectable colorectal cancer is based on 5-fluorouracil (5-FU) chemotherapy in addition to molecular therapies targeting the epidermal growth factor receptor (EGFR) as well as vascular endothelial growth factor (VEGF) with antibodies like bevacizumab. The gene discussed is EGFR; the disease is colorectal cancer.